EXEL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $37,555,216.80

Exelixis Insider Trading History Chart

Exelixis Share Price & Price History

^$56.78

▼ -0.12 (-0.21%)

As of 09/16/2026 04:00 PM ET

Days: 30 | 90 | 365

Exelixis Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/10/2026	Mary C Beckerle	Director	Sell	9,812	$53.66	$526,511.92	16,079
6/1/2026	Jack L Wyszomierski	Director	Sell	3,925	$50.55	$198,408.75	284,384
6/1/2026	Sue Gail Eckhardt	Director	Sell	9,812	$50.14	$491,973.68	16,079
5/26/2026	Dana Aftab	EVP	Sell	43,451	$50.35	$2,187,757.85	594,741
5/20/2026	Patrick J Haley	EVP	Sell	32,110	$49.81	$1,599,399.10	357,638
5/18/2026	Brenda Hefti	SVP	Sell	6,625	$50.21	$332,641.25	106,762
5/18/2026	Christopher J Senner	CFO	Sell	34,901	$50.00	$1,745,050.00	952,317
5/7/2026	George Poste	Director	Sell	60,000	$45.71	$2,742,600.00	118,832
5/7/2026	Maria C. Freire	Director	Sell	20,634	$46.00	$949,164.00	100,819
5/7/2026	Mary C Beckerle	Director	Sell	7,712	$48.45	$373,646.40	17,524
2/24/2026	Dana Aftab	EVP	Sell	47,918	$44.50	$2,132,351.00	616,106
2/19/2026	Dana Aftab	EVP	Sell	29,873	$44.35	$1,324,867.55	664,024
2/18/2026	Brenda Hefti	SVP	Sell	18,669	$44.01	$821,622.69	96,512
2/18/2026	Jack L Wyszomierski	Director	Sell	99,574	$44.01	$4,382,251.74	279,942
2/17/2026	Christopher J Senner	CFO	Sell	30,617	$43.67	$1,337,044.39	976,092
2/17/2026	Patrick J Haley	EVP	Sell	67,814	$43.52	$2,951,265.28	381,908
2/13/2026	Bob Oliver	Director	Sell	30,250	$43.81	$1,325,252.50	21,120
2/13/2026	Christopher J Senner	CFO	Sell	34,278	$43.00	$1,473,954.00	1,042,579
2/13/2026	Sue Gail Eckhardt	Director	Sell	3,856	$43.79	$168,854.24	17,524
11/21/2025	Patrick J Haley	EVP	Sell	28,043	$42.58	$1,194,070.94	374,029
11/20/2025	Patrick J Haley	EVP	Sell	10,000	$42.11	$421,100.00	402,072
11/20/2025	Patrick J Haley	EVP	Sell	34,187	$41.88	$1,431,751.56
11/12/2025	Stelios Papadopoulos	Director	Sell	100,000	$43.55	$4,355,000.00	1,189,228
11/11/2025	Dana Aftab	EVP	Sell	48,383	$42.50	$2,056,277.50	664,778
11/11/2025	Mary C Beckerle	Director	Sell	24,622	$41.93	$1,032,400.46	21,380
6/3/2025	Jack L Wyszomierski	Director	Sell	7,535	$43.09	$324,683.15	358,882
6/2/2025	Sue Gail Eckhardt	Director	Sell	18,838	$42.74	$805,136.12	21,380
5/21/2025	Tomas J. Heyman	Director	Sell	4,544	$44.29	$201,253.76	32,470
5/20/2025	Patrick J Haley	EVP	Sell	34,387	$44.06	$1,515,091.22	412,072
5/16/2025	Amy C Peterson	CMO	Sell	72,776	$45.47	$3,309,124.72	465,393
5/16/2025	Christopher J Senner	CFO	Sell	100,000	$46.00	$4,600,000.00	967,842
5/16/2025	George Poste	Director	Sell	20,634	$45.99	$948,957.66	169,020
5/15/2025	Jeffrey J. Hessekiel	EVP	Sell	25,000	$46.18	$1,154,500.00	693,396
5/15/2025	Patrick J Haley	EVP	Sell	126,383	$47.96	$6,061,328.68	446,459
5/15/2025	Stelios Papadopoulos	Director	Sell	36,508	$44.35	$1,619,129.80	1,279,416
5/14/2025	Patrick J Haley	EVP	Sell	10,000	$42.68	$426,800.00	491,164
5/1/2025	Dana Aftab	EVP	Sell	1,508	$39.00	$58,812.00	693,181
3/3/2025	Patrick J Haley	EVP	Sell	10,000	$38.80	$388,000.00	341,028
2/28/2025	Jack L Wyszomierski	Director	Sell	8,768	$37.80	$331,430.40	356,605
2/28/2025	Jack L Wyszomierski	Director	Sell	8,768	$37.80	$331,430.40	356,605
2/25/2025	Bob Oliver	Director	Sell	18,647	$37.25	$694,600.75	33,514
2/24/2025	Christopher J Senner	CFO	Sell	29,314	$36.14	$1,059,407.96	779,607
2/24/2025	Patrick J Haley	EVP	Sell	52,636	$36.98	$1,946,479.28	303,310
2/14/2025	Mary C Beckerle	Director	Sell	12,210	$34.88	$425,884.80	30,406
11/29/2024	Jeffrey J. Hessekiel	EVP	Sell	60,000	$36.67	$2,200,200.00	486,059
11/22/2024	Patrick J Haley	EVP	Sell	10,000	$35.27	$352,700.00	278,665
11/18/2024	Patrick J Haley	EVP	Sell	41,588	$34.36	$1,428,963.68	288,665
11/5/2024	Dana Aftab	EVP	Sell	96,986	$35.00	$3,394,510.00	498,945
11/1/2024	George Poste	Director	Sell	30,000	$34.00	$1,020,000.00	169,020
11/1/2024	Jeffrey J. Hessekiel	EVP	Sell	50,000	$34.13	$1,706,500.00	530,325
10/30/2024	Dana Aftab	EVP	Sell	1,162	$31.40	$36,486.80	498,945
10/28/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$28.39	$709,750.00	580,325
9/23/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$26.38	$659,500.00	605,325
8/26/2024	Jeffrey J. Hessekiel	EVP	Sell	20,000	$25.79	$515,800.00	630,325
8/14/2024	Maria C. Freire	Director	Sell	8,250	$26.56	$219,120.00	91,007
8/12/2024	Dana Aftab	EVP	Sell	20,883	$27.06	$565,093.98	500,107
8/9/2024	Christopher J Senner	CFO	Sell	125,000	$27.19	$3,398,750.00	721,680
8/8/2024	George Poste	Director	Sell	33,725	$26.89	$906,865.25	199,020
8/7/2024	Dana Aftab	EVP	Sell	95,000	$25.00	$2,375,000.00	520,990
6/4/2024	Jack L Wyszomierski	Director	Sell	8,287	$22.00	$182,314.00	349,499
5/30/2024	David Edward Johnson	Director	Buy	225,000	$20.76	$4,671,000.00	1,525,730
5/28/2024	David Edward Johnson	Director	Buy	200,000	$20.32	$4,064,000.00	1,300,730
5/21/2024	George Poste	Director	Sell	11,686	$20.96	$244,938.56	213,907
5/13/2024	Jack L Wyszomierski	Director	Sell	10,923	$21.37	$233,424.51	338,948
3/21/2024	Alan M. Garber	Director	Sell	19,205	$24.01	$461,112.05	35,703
2/23/2024	Patrick J Haley	EVP	Sell	47,020	$21.45	$1,008,579.00	384,866
2/21/2024	David Edward Johnson	Director	Buy	190,000	$20.70	$3,933,000.00	1,100,730
12/14/2023	Patrick J Haley	EVP	Sell	50,000	$23.35	$1,167,500.00	307,687
12/12/2023	Patrick J Haley	EVP	Sell	14,149	$22.50	$318,352.50	307,687
12/4/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.06	$551,500.00	558,345
11/30/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.01	$550,250.00	583,345
11/27/2023	David Edward Johnson	Director	Buy	120,409	$21.61	$2,602,038.49	910,730

SEC Filings (Institutional Ownership Changes) for Exelixis (NASDAQ:EXEL)

85.27% of Exelixis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Exelixis Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/9/2026	The Manufacturers Life Insurance Company	181,540	$9.88M	0.0%	-1.4%	0.073%
9/9/2026	Sequoia Financial Advisors LLC	20,292	$1.10M	0.0%	+59.7%	0.008%
9/9/2026	Tidal Investments LLC	375,316	$20.42M	0.0%	-1.8%	0.151%
9/9/2026	Archford Capital Strategies LLC	13,038	$0.71M	0.1%	N/A	0.005%
9/9/2026	Krensavage Asset Management LLC	370,693	$20.17M	7.7%	-10.8%	0.150%
9/9/2026	WINTON GROUP Ltd	99,834	$5.43M	0.2%	+1,651.5%	0.040%
9/9/2026	Engineers Gate Manager LP	110,353	$6M	0.1%	-32.5%	0.045%
9/9/2026	Pinnacle Wealth Management Advisory Group LLC	4,801	$0.26M	0.0%	-7.6%	0.002%
9/9/2026	Integrated Wealth Concepts LLC	58,636	$3.19M	0.0%	-25.7%	0.024%
9/9/2026	NewEdge Advisors LLC	32,532	$1.77M	0.0%	-4.3%	0.013%
9/9/2026	IFP Advisors Inc	43,101	$2.35M	0.0%	-0.8%	0.017%
9/9/2026	Squarepoint Ops LLC	473,707	$25.77M	0.0%	+1,649.8%	0.191%
9/9/2026	Baird Financial Group Inc.	437,138	$23.79M	0.0%	+7,459.0%	0.176%
9/9/2026	Arcus Capital Partners LLC	5,662	$0.31M	0.1%	-3.6%	0.002%
9/8/2026	Allworth Financial LP	10,562	$0.58M	0.0%	+4.7%	0.004%
9/8/2026	Arizona State Retirement System	64,832	$3.53M	0.0%	-7.3%	0.026%
9/8/2026	Waverly Advisors LLC	13,174	$0.72M	0.0%	+4.0%	0.005%
9/8/2026	Nykredit A S	8,713	$0.47M	0.0%	N/A	0.004%
9/2/2026	Allianz Asset Management GmbH	666,268	$36.25M	0.0%	-30.2%	0.269%
8/27/2026	Corient Private Wealth LP	79,337	$4.32M	0.0%	-14.7%	0.032%
8/26/2026	Amundi	21,203	$1.15M	0.0%	-38.4%	0.009%
8/26/2026	HighTower Advisors LLC	291,162	$15.84M	0.0%	+85.7%	0.118%
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	93,199	$5.07M	0.0%	N/A	0.038%
8/23/2026	Wedmont Private Capital	8,342	$0.47M	0.0%	+13.3%	0.003%
8/23/2026	HB Wealth Management LLC	26,737	$1.46M	0.0%	-8.0%	0.011%
8/22/2026	AlphaGrep UK Ltd	4,770	$0.26M	0.1%	N/A	0.002%
8/22/2026	Turner Financial Group Inc.	6,167	$0.34M	0.3%	N/A	0.002%
8/22/2026	BAM Wealth Management LLC	8,257	$0.45M	0.3%	+8.7%	0.003%
8/22/2026	Three Seasons Wealth LLC	30,814	$1.68M	0.2%	-48.2%	0.012%
8/22/2026	denkapparat Operations GmbH	33,152	$1.80M	0.6%	+38.5%	0.013%
8/22/2026	Concurrent Investment Advisors LLC	22,791	$1.24M	0.0%	-38.4%	0.009%
8/21/2026	Continuum Advisory LLC	1,403	$76K	0.0%	N/A	0.001%
8/21/2026	Nykredit A S	8,713	$0.47M	0.0%	N/A	0.004%
8/21/2026	Legacy Financial Advisors Inc.	4,722	$0.26M	0.0%	N/A	0.002%
8/20/2026	BTG Pactual Asset Management US LLC	6,873	$0.37M	0.0%	N/A	0.003%
8/20/2026	Northwestern Mutual Wealth Management Co.	1,043	$57K	0.0%	-53.3%	0.000%
8/20/2026	Greenwood Capital Associates LLC	8,152	$0.44M	0.0%	-3.5%	0.003%
8/20/2026	Greenleaf Trust	4,560	$0.25M	0.0%	N/A	0.002%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,201,307	$65.36M	0.0%	-7.0%	0.485%
8/19/2026	New Mexico Educational Retirement Board	52,155	$2.84M	0.1%	-9.9%	0.021%
8/19/2026	Van ECK Associates Corp	262,281	$14.27M	0.0%	+0.9%	0.106%
8/19/2026	Hsbc Holdings PLC	47,538	$2.59M	0.0%	-27.9%	0.019%
8/19/2026	Wellington Management Group LLP	107,573	$5.85M	0.0%	+31.0%	0.043%
8/18/2026	Beacon Pointe Advisors LLC	7,240	$0.39M	0.0%	+28.7%	0.003%
8/18/2026	Empowered Funds LLC	272,490	$14.83M	0.1%	-18.8%	0.110%
8/18/2026	United Capital Financial Advisors LLC	7,534	$0.41M	0.0%	-26.6%	0.003%
8/18/2026	Caitlin John LLC	12,270	$0.67M	0.4%	N/A	0.005%
8/18/2026	Equitable Holdings Inc.	7,495	$0.41M	0.0%	-63.6%	0.003%
8/18/2026	Jefferies Financial Group Inc.	19,723	$1.07M	0.0%	-64.9%	0.008%
8/18/2026	Public Employees Retirement System of Ohio	95,518	$5.20M	0.0%	-8.7%	0.039%
8/17/2026	Redwood Investment Management LLC	21,430	$1.17M	0.1%	-11.6%	0.009%
8/17/2026	Transamerica Financial Advisors LLC	4,673	$0.25M	0.0%	+41.7%	0.002%
8/17/2026	Corient Private Wealth LP	54,245	$2.95M	0.0%	-41.7%	0.022%
8/17/2026	Corient Private Wealth LP	79,467	$4.32M	0.0%	N/A	0.032%
8/17/2026	Bank of America Corp DE	2,149,397	$116.95M	0.0%	+30.7%	0.867%
8/15/2026	Strategic Global Advisors LLC	97,747	$5.32M	0.8%	N/A	0.039%
8/15/2026	Caisse de depot et placement du Quebec	2,094,299	$113.95M	0.2%	N/A	0.845%
8/15/2026	Man Group plc	456,761	$24.85M	0.0%	N/A	0.184%
8/15/2026	Polar Asset Management Partners Inc.	4,908	$0.27M	0.0%	N/A	0.002%
8/15/2026	Jupiter Topco LLC	1,236,393	$67.30M	0.0%	N/A	0.499%
8/14/2026	Hsbc Holdings PLC	47,538	$2.59M	0.0%	N/A	0.019%
8/14/2026	Canada Pension Plan Investment Board	651,800	$35.46M	0.0%	N/A	0.263%
8/14/2026	Legal & General Group Plc	359,499	$19.56M	0.0%	N/A	0.145%
8/14/2026	The Manufacturers Life Insurance Company	181,540	$9.88M	0.0%	N/A	0.073%
8/14/2026	L2 Asset Management LLC	125,702	$6.84M	0.7%	N/A	0.051%
8/14/2026	Whalen Wealth Management Inc.	10,226	$0.56M	0.3%	N/A	0.004%
8/14/2026	Algert Global LLC	117,529	$6.40M	0.1%	-9.0%	0.047%
8/13/2026	OMERS ADMINISTRATION Corp	31,547	$1.72M	0.0%	N/A	0.013%
8/13/2026	Sanctuary Advisors LLC	41,660	$2.27M	0.0%	N/A	0.017%
8/13/2026	Capital Square LLC	3,901	$0.22M	0.1%	N/A	0.002%
8/13/2026	Meiji Yasuda Asset Management Co Ltd.	5,818	$0.32M	0.0%	N/A	0.002%
8/13/2026	Globeflex Capital L P	254,993	$13.87M	1.8%	N/A	0.103%
8/13/2026	Bank of Nova Scotia	419,730	$22.84M	0.0%	N/A	0.169%
8/12/2026	Commerce Bank	78,937	$4.30M	0.0%	N/A	0.032%
8/12/2026	Northwestern Mutual Wealth Management Co.	1,043	$57K	0.0%	N/A	0.000%
8/12/2026	Quantbot Technologies LP	5,933	$0.32M	0.0%	N/A	0.002%
8/12/2026	Evolve Private Wealth LLC	38,016	$2.07M	0.1%	N/A	0.015%
8/12/2026	Landscape Capital Management L.L.C.	19,340	$1.05M	0.1%	N/A	0.008%
8/12/2026	EP Wealth Advisors LLC	23,865	$1.30M	0.0%	N/A	0.010%
8/12/2026	Ieq Capital LLC	451,768	$24.58M	0.1%	N/A	0.182%
8/12/2026	Heron Bay Capital Management	114,799	$6.25M	0.6%	N/A	0.046%
8/12/2026	Callan Family Office LLC	4,007	$0.22M	0.0%	N/A	0.002%
8/12/2026	Expressive Wealth LLC	12,676	$0.69M	0.7%	N/A	0.005%
8/12/2026	C M Bidwell & Associates Ltd.	1,452	$79K	0.0%	N/A	0.001%
8/11/2026	Keating Financial Advisory Services Inc.	10,863	$0.59M	0.1%	N/A	0.004%
8/11/2026	Allworth Financial LP	10,562	$0.58M	0.0%	N/A	0.004%
8/11/2026	NFJ Investment Group LLC	338,045	$18.39M	0.6%	N/A	0.134%
8/11/2026	Virtus Advisers LLC	14,769	$0.80M	0.3%	N/A	0.006%
8/11/2026	Vise Technologies Inc.	15,708	$0.86M	0.0%	N/A	0.006%
8/11/2026	E Fund Management Co. Ltd.	7,870	$0.43M	0.0%	N/A	0.003%
8/11/2026	Abacus FCF Advisors LLC	133,936	$7.29M	1.3%	N/A	0.053%
8/10/2026	Johnson Financial Group Inc.	3,992	$0.22M	0.0%	N/A	0.002%
8/10/2026	NewEdge Wealth LLC	51,642	$2.81M	0.0%	N/A	0.021%
8/10/2026	Diversify Advisory Services LLC	5,567	$0.31M	0.0%	N/A	0.002%
8/8/2026	RHS Financial LLC	12,779	$0.70M	0.3%	N/A	0.005%
8/8/2026	JLB & Associates Inc.	48,849	$2.66M	0.4%	N/A	0.019%
8/8/2026	Meeder Advisory Services Inc.	5,298	$0.29M	0.0%	N/A	0.002%
8/7/2026	Citizens Financial Group Inc. RI	8,793	$0.48M	0.0%	N/A	0.003%
8/7/2026	Grandfield & Dodd LLC	27,109	$1.48M	0.1%	N/A	0.011%
8/7/2026	BlackRock Inc.	29,075,377	$1.58B	0.0%	N/A	11.568%

Data available starting January 2016

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. It develops zanzalintinib, a novel, potent, next-generation oral tyrosine kinase inhibitor (TKI) that targets VEGF receptors, MET and the TAM kinases (TYRO3, AXL and MER); and XB002, a next-generation tissue factor (TF)-targeting ADC, administered via intravenous infusion and composed of a human monoclonal antibody (mAb) against TF that is conjugated to an auristatin-based microtubulin inhibitor (MTI) payload. It has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited, as well as clinical development agreement with Sairopa B.V. for ADU-1805. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.

Today's Range

Now: $56.78

$56.33

$57.78

50 Day Range

MA: $55.37

$50.38

$59.13

52 Week Range

Now: $56.78

$33.76

$59.72

Volume

1,879,629 shs

Average Volume

1,980,701 shs

Market Capitalization

$14.07 billion

P/E Ratio

17.86

Dividend Yield

N/A

Beta

0.42

Who are the company insiders with the largest holdings of Exelixis?: Exelixis' top insider shareholders include:
George A Scangos (Director)
David Edward Johnson (Director)
Stelios Papadopoulos (Director)
Christopher J Senner (CFO)
Michael Morrissey (CEO)
Jeffrey Hessekiel (EVP)
Dana Aftab (EVP)
Lance Willsey (Director)
Patrick J Haley (EVP)
Amy C Peterson (CMO)
Learn More about top insider investors at Exelixis.
Who are the major institutional investors of Exelixis?: Exelixis' top institutional investors include:
BlackRock Inc. — 11.57%
Bank of America Corp DE — 0.87%
Caisse de depot et placement du Quebec — 0.85%
Bank of New York Mellon Corp — 0.79%
Jupiter Topco LLC — 0.50%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.48%
Learn More about top institutional investors of Exelixis stock.
Which major investors are selling Exelixis stock?: During the previous quarter, EXEL stock was sold by these institutional investors:
Allianz Asset Management GmbH
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Empowered Funds LLC
Engineers Gate Manager LP
Krensavage Asset Management LLC
Corient Private Wealth LP
Jefferies Financial Group Inc.
Three Seasons Wealth LLC
Within the previous year, company insiders that have sold Exelixis company stock include:
Stelios Papadopoulos (Director)
Christopher J Senner (CFO)
Dana Aftab (EVP)
Patrick J Haley (EVP)
Jack L Wyszomierski (Director)
George Poste (Director)
Brenda Hefti (SVP)
Maria C Freire (Director)
Mary C Beckerle (Director)
Bob Oliver (Director)
Sue Gail Eckhardt (Director)
Learn More investors selling Exelixis stock.
Which major investors are buying Exelixis stock?: In the previous quarter, EXEL stock was acquired by institutional investors including:
BlackRock Inc.
Caisse de depot et placement du Quebec
Bank of New York Mellon Corp
Jupiter Topco LLC
Canada Pension Plan Investment Board
Bank of America Corp DE
Man Group plc
Ieq Capital LLC